Smart Watch Insights for Prevention of Exacerbations and Enhance Rehabilitation - Movement Study
NCT ID: NCT06011356
Last Updated: 2024-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
1000 participants
OBSERVATIONAL
2023-08-30
2026-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. To deliver a scalable wellbeing programme to the local population of Imperial College Healthcare NHS Trust, focusing on movement.
2. To describe the natural history of long-term conditions using digital data from a smartwatch.
3. To identify digital information that is routinely collected by a smart watch that can be used to predict outcomes in patients with long term conditions.
4. To identify factors that determine whether participants engage with and improve in a movement programme.
Adult patients who are registered to the Imperial NHS Care Information Exchange (CIE), an NHS patient-facing electronic health record, are eligible to participate in the study. Participants will receive a smart watch for self-monitoring of their movement and wellbeing and be asked to wear the device as much as possible. They will be asked to download a smartphone application called Connected Life, which displays movement and information on heart rate, breathing and oxygen levels to both the participant and the research team (digital data). Participants will receive secure login details for the Connected Life application from the research team, to ensure data privacy. The research team will look at participants' health records, and attempt to identify associations between the digital data and clinical information. This will allow the research team to identify digital data that predicts the onset and natural history of long term conditions, which may potentially allow for earlier diagnosis for future patients. The primary outcome of the study is the identification of trends in movement based on step-count data recorded by the smartwatch.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wearable Devices Empowering Active Health Initiatives for High-Risk Stroke Populations
NCT06935513
IntelligentCare: Wearable-based Intervention
NCT05777291
A Prospective Patient Reported Outcomes and Wearables Study in Myeloproliferative Neoplasms
NCT06334913
Accuracy of Smartwatches in Measuring Oxygen Levels in Patients With Pulmonary Hypertension: A Pilot Study
NCT07311135
Wearable Technology for Hospital Inpatients
NCT02527408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smartwatch
Activity tracker (step count, calories burned), measures heart rate, heart variability and other physiological variables.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Registered with the patient-facing electronic health record (Care Information Exchange)
Exclusion Criteria
* Arm or wrist injury or condition prohibiting the safe use of a smartwatch
* Any visual impairment preventing the use of the smartwatch or smartphone application.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Imperial College London
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nicholas S Peters, MD
Role: PRINCIPAL_INVESTIGATOR
Imperial College Healthcare NHS Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Imperial College Healthcare NHS Trust
London, United Kingdom (+44), United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22HH7499
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.